Quantitative determination and metabolic profiling of synthetic cathinone eutylone in vitro and in urine samples by liquid chromatography tandem quadrupole time‐of‐flight mass spectrometry

Metabolic Profile of Four Selected Cathinones in Microsome Incubations: Identification of Phase I and II Metabolites by Liquid Chromatography High Resolution Mass Spectrometry

(2021) Beatriz T. Lopes et al.   Frontiers in Chemistry

Synthetic cathinone poisoning from ingestion of drug-laced “instant coffee packets” in Taiwan

(2021) H-H Chou et al.   HUMAN & EXPERIMENTAL TOXICOLOGY

Potential of the zebrafish model for the forensic toxicology screening of NPS: A comparative study of the effects of APINAC and methiopropamine on the behavior of zebrafish larvae and mice

(2020) Elisa Morbiato et al.   NEUROTOXICOLOGY

How to Study the Metabolism of New Psychoactive Substances for the Purpose of Toxicological Screenings—A Follow-Up Study Comparing Pooled Human Liver S9, HepaRG Cells, and Zebrafish Larvae

(2020) Lea Wagmann et al.   Frontiers in Chemistry

Study of the in vitro and in vivo metabolism of a novel synthetic cannabinoid PX-2 in human liver microsomes and zebrafish

(2020) Hai Hei et al.   INTERNATIONAL JOURNAL OF MASS SPECTROMETRY

Eutylone Intoxications—An Emerging Synthetic Stimulant in Forensic Investigations

(2020) Alex J Krotulski et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

New Synthetic Cannabinoids Metabolism and Strategies to Best Identify Optimal Marker Metabolites

(2019) Xingxing Diao et al.   Frontiers in Chemistry

In Vitro Metabolic Profile Elucidation of Synthetic Cannabinoid APP-CHMINACA (PX-3)

(2019) Brandon C Presley et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Phase I metabolism of synthetic cannabinoid receptor agonist PX‐1 (5F‐APP‐PICA) via incubation with human liver microsomes and UHPLC–HRMS

(2019) Brandon C. Presley et al.   BIOMEDICAL CHROMATOGRAPHY

In vitro Characterization of NPS Metabolites Produced by Human Liver Microsomes and the HepaRG Cell Line Using Liquid Chromatographyhigh Resolution Mass Spectrometry (LC-HRMS) Analysis: Application to Furanyl Fentanyl

(2018) Camille Richeval et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Dibutylone (bk-DMBDB): Intoxications, Quantitative Confirmations and Metabolism in Authentic Biological Specimens

(2018) Alex J Krotulski et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

N-Ethyl Pentylone (Ephylone) Intoxications: Quantitative Confirmation and Metabolite Identification in Authentic Human Biological Specimens

(2018) Alex J Krotulski et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

In vitro metabolism of a novel synthetic cannabinoid, EAM-2201, in human liver microsomes and human recombinant cytochrome P450s

(2016) Ju Hyun Kim et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Metabolic characterization of AH-7921, a synthetic opioid designer drug:in vitrometabolic stability assessment and metabolite identification, evaluation ofin silicoprediction, andin vivoconfirmation

(2015) Ariane Wohlfarth et al.   Drug Testing and Analysis

Thein vivoandin vitrometabolism and the detectability in urine of 3’,4’-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MSn

(2013) Markus R. Meyer et al.   Drug Testing and Analysis

Identification of substituted cathinones: 3,4-Methylenedioxy derivatives by high performance liquid chromatography–quadrupole time of flight mass spectrometry

(2013) Emilia Fornal   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

In vitro approaches to studying the metabolism of new psychoactive compounds

(2011) Frank T. Peters et al.   Drug Testing and Analysis

Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine

(2009) Kei Zaitsu et al.   FORENSIC SCIENCE INTERNATIONAL